Search Results - "Pruett, Jacob E"

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome by Pruett, Jacob E, Torres Fernandez, Edgar D, Everman, Steven J, Vinson, Ruth M, Davenport, Kacey, Logan, Madelyn K, Ye, Stephanie A, Romero, Damian G, Yanes Cardozo, Licy L

“…Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women. PCOS is characterized by hyperandrogenism and ovulatory…”
Get full text

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors by Pruett, Jacob E, Romero, Damian G, Yanes Cardozo, Licy L

“…Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive-age women. PCOS is characterized by androgen excess, oligo/anovulation,…”
Get full text

Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition by Pruett, Jacob E, Everman, Steven J, Hoang, Ngoc H, Salau, Faridah, Taylor, Lucy C, Edwards, Kristin S, Hosler, Jonathan P, Huffman, Alexandra M, Romero, Damian G, Yanes Cardozo, Licy L

“…Abstract Background Polycystic ovary syndrome (PCOS), characterized by androgen excess and ovulatory dysfunction, is associated with a high prevalence of…”
Get full text

Temporal Development of Cardiometabolic Complications in A Hyperandrogenemic Model of Polycystic Ovary Syndrome by Pruett, Jacob E., Everman, Steven, Romero, Damian G., Yanes Cardozo, Licy L.

“…Introduction Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in young women, being characterized by androgen excess and irregular…”
Get full text

Androgens, the kidney, and COVID-19: an opportunity for translational research by Yanes Cardozo, Licy L, Rezq, Samar, Pruett, Jacob E, Romero, Damian G

“…Coronavirus disease 2019 (COVID-19) has reached pandemic proportions, affecting millions of people worldwide. Severe acute respiratory syndrome coronavirus-2…”
Get more information

Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women by Pruett, Jacob E, Lirette, Seth T, Romero, Damian G, Yanes Cardozo, Licy L

“…In addition to their antihyperglycemic action, sodium-glucose cotransporter-2 (SGLT2) inhibitors are used in patients with type 2 diabetes due to their…”
Get full text

7098 Paradoxical Worsening of Dyslipidemia with Tirzepatide by Pruett, Jacob E, Carranza Leon, Barbara Gisella

“…Abstract Disclosure: J.E. Pruett: None. B. Carranza Leon: None. Background: While weight loss typically is associated with improvement in dyslipidemia (DLD),…”
Get full text

Role of Obesity and Adrenergic Activation in the Androgen‐Induced Cardiometabolic Abnormalities in PCOS by Torres Fernandez, Edgar D., McClung, Sally J., Morato, Jemylle G., Everman, Steven J., Pruett, Jacob E., Iliescu, Radu, Romero, Damian G., Yanes Cardozo, Licy L.

“…Abstract only Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is diagnosed by the combination of…”
Get full text

Impact of Sodium-Glucose Cotransporter-2 Inhibition on the Cardiometabolic Profile of Polycystic Ovary Syndrome by Pruett, Jacob E

“…Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. PCOS is characterized by androgen excess,…”
Get full text

Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost? by Pruett, Jacob E, Everman, Steven, Fernandez, Edgar David Torres, Davenport, Kacey, Romero, Damian G, Cardozo, Licy L Yanes

“…Abstract Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is characterized by androgen…”
Get full text